Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Drug Resistance

Free Subscription 10.11.2025 13 Antimicrob Agents Chemother 4 Infect Control Hosp Epidemiol 1 J Infect Chemother 1 J Infect Dis 1 J Med Microbiol 1 PLoS Med 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. MORAN-BARRIO J, Giacone L, Brambilla L, Fabbri C, et al
   The lipoprotein biosynthesis pathway: key to OXA-mediated carbapenem resistance in Acinetobacter baumannii.
   Antimicrob Agents Chemother. 2025 Nov 4:e0109925. doi: 10.1128/aac.01099.
   PubMed         Abstract available
   
   
2. HE G, Zeng S, Banki LT, Zhou W, et al
   Clinical emergence of inducible macrolide resistance mediated by acquired erm(41) C28T mutation in Mycobacterium abscessus.
   Antimicrob Agents Chemother. 2025 Nov 6:e0115325. doi: 10.1128/aac.01153.
   PubMed         Abstract available
   
   
3. FINDLAY J, Nordmann P, Jayol A, Seth-Smith HMB, et al
   Carbapenem resistance in a Klebsiella quasipneumoniae isolate resulting from production of CTX-M-33 and OmpK36 porin deficiency.
   Antimicrob Agents Chemother. 2025 Nov 6:e0121425. doi: 10.1128/aac.01214.
   PubMed        
   
   
4. LODISE TP, Min J, Nathanson BH, Yucel E, et al
   Comparison of early treatment with ceftolozane/tazobactam versus polymyxin-based therapy of pneumonia due to MDR Pseudomonas aeruginosa (PUMA).
   Antimicrob Agents Chemother. 2025;69:e0056925.
   PubMed         Abstract available
   
   
5. WANG C, Feng Y, Zong Z
   Colistin heteroresistance in Enterobacter due to base heterozygosity at certain phoP and phoQ locations.
   Antimicrob Agents Chemother. 2025;69:e0071325.
   PubMed         Abstract available
   
   
6. KUNZ COYNE AJ, Gray R, May E, Curry H, et al
   Molecular and pharmacodynamic insights into beta-lactam therapy for high-inoculum Enterobacter cloacae complex infections.
   Antimicrob Agents Chemother. 2025;69:e0117025.
   PubMed         Abstract available
   
   
7. RAMIREZ D, Ramirez DM, Arora R, Arthur G, et al
   Noncytotoxic polymyxin derivatives enhance antibiotic action against multidrug-resistant Gram-negative bacteria.
   Antimicrob Agents Chemother. 2025;69:e0071225.
   PubMed         Abstract available
   
   
8. MASSIC L, Doorley LA, Jones SJ, Richardson I, et al
   Acquired amphotericin B resistance attributed to a mutated ERG3 in Candidozyma auris.
   Antimicrob Agents Chemother. 2025;69:e0060125.
   PubMed         Abstract available
   
   
9. SHINOHARA T, Wada A, Abe M, Oiki S, et al
   A zinc-chelating cyclic alkyl polyamine compound is efficient and safe in a murine model of multidrug-resistant Candida auris infection.
   Antimicrob Agents Chemother. 2025 Sep 26:e0085625. doi: 10.1128/aac.00856.
   PubMed         Abstract available
   
   
10. WIEDERHOLD NP
    Case Commentary: Successful use of olorofim for the treatment of multi-drug-resistant Lomentospora prolificans infection in a child.
    Antimicrob Agents Chemother. 2025;69:e0107225.
    PubMed         Abstract available
    
    
11. VENA A, Bartalucci C, Muccio M, Tiseo G, et al
    Comparative effectiveness of echinocandins and liposomal amphotericin B for fluconazole-resistant Candida parapsilosis bloodstream infections.
    Antimicrob Agents Chemother. 2025 Sep 30:e0035525. doi: 10.1128/aac.00355.
    PubMed         Abstract available
    
    
12. ALVARADO CASAS ML, Triana Diaz JA, Montilla-Escudero E, Prada Cardozo DA, et al
    Genomic epidemiology of Colombian resistant Candida auris isolates.
    Antimicrob Agents Chemother. 2025 Oct 7:e0072525. doi: 10.1128/aac.00725.
    PubMed         Abstract available
    
    
13. XUE R, Gao S, de Hoog S, van Diepeningen A, et al
    Olorofim activity against multidrug-resistant Fusarium unveils intra-species and inter-species variability.
    Antimicrob Agents Chemother. 2025;69:e0096125.
    PubMed         Abstract available
    
    

    
    Infect Control Hosp Epidemiol

14. SCHECHNER V, Efrati-Epchtien R, Cohen A, Temkin E, et al
    Transmission of carbapenem-resistant Acinetobacter baumannii in post-acute care hospitals: an FTIR-based analysis of strain similarity.
    Infect Control Hosp Epidemiol. 2025 Nov 4:1-7. doi: 10.1017/ice.2025.10337.
    PubMed         Abstract available
    
    
15. WU H, England R, Huang X, Lutgring J, et al
    Concise communication title: wide adoption of rapid molecular detection of antimicrobial resistance markers for use with blood cultures: implications for national surveillance of antimicrobial resistance.
    Infect Control Hosp Epidemiol. 2025 Nov 6:1-4. doi: 10.1017/ice.2025.
    PubMed         Abstract available
    
    
16. WILLIAMS V, Chevrier J, Elligsen M, Lam PW, et al
    Antibiotic-exposure guided prevalence screening for vancomycin-resistant Enterococcus: better value for hospitals.
    Infect Control Hosp Epidemiol. 2025 Nov 4:1-2. doi: 10.1017/ice.2025.10332.
    PubMed        
    
    
17. LEE PS, OYong K, Shah AN, Thiel C, et al
    Environmental and human health impact of contact precaution use for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in Los Angeles County.
    Infect Control Hosp Epidemiol. 2025 Nov 7:1-3. doi: 10.1017/ice.2025.10338.
    PubMed         Abstract available
    
    

    
    J Infect Chemother

18. JUNG J, Kim YK, Chang E, Bae S, et al
    Corrigendum to 'The origin of sequence type 72 community-associated methicillin-resistant Staphylococcus aureus (MRSA) and fusidic acid (FA) resistant sequence type 5 MRSA: Analysis of FA resistance and spa type in a single center in South Korea'[Jour
    J Infect Chemother. 2025 Oct 30:102847. doi: 10.1016/j.jiac.2025.102847.
    PubMed        
    
    

    
    J Infect Dis

19. JIANG JH, Lim CX, Lai X, Kostoulias X, et al
    Daptomycin-Loaded Nanocarriers Facilitate Synergistic Killing of Methicillin-Resistant Staphylococcus aureus via Lipid-Mediated Interactions and Targeting.
    J Infect Dis. 2025 Nov 4:jiaf492. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Microbiol

20. HUYNH T, Lam T, Pham N, Luong L, et al
    Mathematical modelling of synergistic triple-antibiotic therapy against carbapenem-resistant Acinetobacter baumannii at clinically achievable concentrations.
    J Med Microbiol. 2025;74.
    PubMed         Abstract available
    
    

    
    PLoS Med

21. WATERLOW NR, Chandler CIR, Cooper BS, Moore CE, et al
    Combining demographic shifts with age-based resistance prevalence to estimate future antimicrobial resistance burden in Europe and implications for targets: A modelling study.
    PLoS Med. 2025;22:e1004579.
    PubMed         Abstract available
    
    

    
    PLoS One

22. LIAO C, Peng J, Luo S, Xie X, et al
    Antimicrobial multidrug resistance of Escherichia coli from broiler farms in Zhanjiang, China.
    PLoS One. 2025;20:e0335518.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

23. HU L, Zhang A, Warshel A
    Exploring evolutionary trajectories of drug resistance.
    Proc Natl Acad Sci U S A. 2025;122:e2517715122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.